Collectively 248 breast/ovarian cancer families have thus far been screened for BRCA2 mutations, and 17 have been identified (van der Looij et al, 2000, Grzybowska et al, 2000 and Górski unpublished data). The gene discussed is BRCA2; the disease is ovarian carcinoma.